REPL: Bathi resik saben saham (EPS TTM) Replimune Corp
High barriers to entry in the biolaboratory sector limit competition within the viral platform niche. Replimune Group, Inc. (REPL) relies on its own cGMP center in the US, which ensures sterility and stability of drug supplies. The 12-month net income per share history confirms the financial dynamics, where the mark -2.94 characterizes this parameter. Management is currently adapting the structure in anticipation of upcoming clinical trial results.
Ringkesan rincian data analitis Replimune Group Inc (REPL)
- rega saham lan prakiraan rega para ahli:
- informasi kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Rasio Total Utang marang Ekuitas Replimune Group, Inc.|REPL - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Replimune Corp|REPL - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Replimune Group, Inc.|REPL - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Replimune|Indikator likuiditas cepet replimune.com
- data bathi lan kelipatan valuasi:
REPL - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Replimune Group, Inc.|REPL - Nilai perusahaan marang bathi resik|Pangali Forward P/E Replimune|REPL - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Replimune Group, Inc.|REPL - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Replimune|REPL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan replimune.com|REPL - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Replimune Group, Inc.
Pambiji fundamental:REPL - Replimune Group, Inc.
While Replimune Group, Inc. (REPL) management adapts its structure to clinical trial results and the R&D roadmap, the company's financial stability depends on capital efficiency. The rolling annual net income per share, which has reached -2.94, measures equity income adjusted for issuance volume, allowing investors to identify one-time anomalies in the fundamental results of this high-risk biopharmaceutical asset.
Pesaing utama
IBRX: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku IMCR (immunocore.com)|JANX: Bathi resik saben saham (EPS TTM)|RCUS - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Zymeworks Corp|Bathi resik saben saham sajrone 12 wulan pungkasan Tango Therapeutics Corp (TNGX)|Bathi saben saham sajrone rolas wulan pungkasan Iovance Biotherapeutics (IOVA)|Bathi resik saben saham sajrone 12 wulan pungkasan immatics.com IMTX|Xencor - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) Compass Therapeutics Inc CMPX|LYEL - Bathi saben saham sajrone rolas wulan pungkasan|IPHA (Innate Pharma S.A) - Bathi saben saham sajrone 12 wulan pungkasan|pyxisoncology.com (PYXS) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan Compugen (CGEN)|Bathi resik saben saham sajrone 12 wulan pungkasan IOBT|STRO - Bathi resik saben saham sajroning taun lumaku|Bathi resik saben saham sajrone 12 wulan pungkasan INKT (MiNK)|Bathi saben saham sajrone patang kuartal pungkasan HOWL|Bathi resik saben saham (EPS TTM) IMMX (Immix Biopharma)|Bathi saben saham sajroning taun lumaku ALXO|Cue Biopharma, Inc. - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan PDS Biotechnology|sonnetbio.com (SONN) - Bathi saben saham sajrone rolas wulan pungkasan|MAIA Bio - Bathi saben saham sajroning taun lumaku|LIMN (Liminatus Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Lava Tx|Bathi saben saham sajrone rolas wulan pungkasan NextCure (NXTC)|LPTX: Bathi saben siji saham sajrone 12 wulan pungkasan|Intensity Therapeutics, Inc. - Bathi resik saben saham sajrone 12 wulan pungkasan|Sensei Biotherapeutics Inc (SNSE) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|TOVX - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku GRTS (Gritstone bio, Inc.)|KA: Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan NexImmune Inc (NEXI)|Bathi saben saham sajrone rolas wulan pungkasan Turnstone Biologics Corp|Vaccinex Inc - Bathi saben siji saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Harpoon Therapeutics (HARP)
